inflammatory bowel disease, or after organ transplants. They may be taken orally, injected, applied to the skin, or inhaled, ...

Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.

Still, doctors say there is a need for more awareness of a rare and potentially life-threatening condition involving cortisol, known as Cushing syndrome. In a new editorial from MerckManuals.com ...

Cushing’s syndrome survivor and public health advocate ... Fari called on President Bola Ahmed Tinubu’s administration to invest in rare disease research, strengthen advocacy, and train ...

Previously, the treatment had been indicated for Cushing disease, a subtype of Cushing syndrome. Isturisa is a cortisol synthesis inhibitor. By blocking 11-beta-hydroxylase, the enzyme responsible ...

The US FDA has approved a new orphan drug to treat patients with Cushing’s disease who cannot be helped through surgery. Novartis’ Signifor (pasireotide diaspartate) injection has been ...

In his tear-jerking memoir, Surviving Cushing's Disease: A Young Man's Journey, Chuck Knueve recounts the gritty, emotional story of his son's battle to be diagnosed with Cushing's disease ...

The primary treatment for Cushing's syndrome remains surgical although residual or recurrent disease is common. Medical therapy should be considered in patients who have failed to achieve ...

Grossman, MD, University of Oxford; Fellow, Green-Templeton College, addresses common patient questions around Cushing syndrome. 1. What causes Cushing syndrome? Adrenal glands release hormones ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...